Pluristem Therapeutics Inc.
PSTI · NASDAQ
6/30/2025 | 6/30/2021 | 6/30/2020 | 6/30/2019 | |
|---|---|---|---|---|
| Market Cap | $63,370 | $111,330 | $160,864 | $72,764 |
| - Cash | $5,895 | $31,241 | $8,270 | $4,106 |
| + Debt | $6,761 | $24,584 | $1,585 | $0 |
| Enterprise Value | $64,236 | $104,673 | $154,179 | $68,658 |
| Revenue | $1,336 | $0 | $23 | $54 |
| % Growth | – | -100% | -57.4% | – |
| Gross Profit | $654 | $0 | $23 | $52 |
| % Margin | 49% | – | 100% | 96.3% |
| EBITDA | -$23,329 | -$48,417 | -$27,386 | -$33,570 |
| % Margin | -1,746.2% | – | -119,069.6% | -62,166.7% |
| Net Income | -$23,250 | -$49,865 | -$29,152 | -$35,307 |
| % Margin | -1,740.3% | – | -126,747.8% | -65,383.3% |
| EPS Diluted | -3.56 | -1.77 | -1.6 | -2.86 |
| % Growth | -101.1% | -10.6% | 44.1% | – |
| Operating Cash Flow | -$18,211 | -$30,910 | -$26,369 | -$29,453 |
| Capital Expenditures | -$1,618 | -$373 | -$270 | -$239 |
| Free Cash Flow | -$19,829 | -$31,283 | -$26,639 | -$29,692 |